PMC Links for Nucleotide (Select 54112405) - PMC

Select item 66887891.

Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact

Nutan V. Badgujar, Bhoomi V. Tarapara, Franky D. Shah

PLoS One. 2019; 14(8): e0220711. Published online 2019 Aug 9. doi: 10.1371/journal.pone.0220711

PMCID:: PMC6688789

Abstract Article PDF–1.0M

Select item 66606722.

Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report

Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe, Stavroula Kampouri, Mehmet Ali Kocdor, George Nasioulas

BMC Med Genet. 2019; 20: 131. Published online 2019 Jul 26. doi: 10.1186/s12881-019-0862-3

PMCID:: PMC6660672

Abstract Article PDF–786K

Select item 11710703.

Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses.

R G Martinho, H D Lindsay, G Flaggs, A J DeMaggio, M F Hoekstra, A M Carr, N J Bentley

EMBO J. 1998 Dec 15; 17(24): 7239–7249. doi: 10.1093/emboj/17.24.7239

PMCID:: PMC1171070

Summary PDF–702K

Select item 3164874.

S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe

Howard D. Lindsay, Dominic J.F. Griffiths, Rhian J. Edwards, Per U. Christensen, Johanne M. Murray, Fekret Osman, Nancy Walworth, Antony M. Carr

Genes Dev. 1998 Feb 1; 12(3): 382–395. doi: 10.1101/gad.12.3.382

PMCID:: PMC316487

Abstract Article PDF–1.2M

Select item 70453535.

BRCA2 genemutation, c.2808_2811delACAA (p.Ala938Profs), in malebreastcancer – clinicopathologicalanalysisbased on a case report

Joanna Huszno, Anna Fiszer-Kierzkowska, Wojciech Pigłowski, Magdalena Mazur

Prz Menopauzalny. 2019 Dec; 18(4): 227–229. Published online 2020 Jan 15. doi: 10.5114/pm.2019.93120

PMCID:: PMC7045353

Abstract Article PDF–67K

Select item 61833416.

Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility

Sara Ciceri, Beatrice Gamba, Paola Corbetta, Patrizia Mondini, Monica Terenziani, Serena Catania, Marilina Nantron, Maurizio Bianchi, Paolo D’Angelo, Federica Torri, Fabio Macciardi, Paola Collini, Martina Di Martino, Fraia Melchionda, Andrea Di Cataldo, Filippo Spreafico, Paolo Radice, Daniela Perotti, on behalf of the AIEOP study group

Oncotarget. 2018 Sep 25; 9(75): 34079–34089. Published online 2018 Sep 25. doi: 10.18632/oncotarget.26123

PMCID:: PMC6183341

Abstract Article PDF–2.4M

Select item 58199217.

shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1

You-Sheng Huang, Na Jie, Yi-Xin Zhang, Ke-Jian Zou, Yang Weng

Int J Mol Med. 2018 Mar; 41(3): 1397–1408. Published online 2017 Dec 22. doi: 10.3892/ijmm.2017.3345

PMCID:: PMC5819921

Abstract Article PDF–1.5M

Select item 57989828.

The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants

Miriam S. Reuter, Susan Walker, Bhooma Thiruvahindrapuram, Joe Whitney, Iris Cohn, Neal Sondheimer, Ryan K.C. Yuen, Brett Trost, Tara A. Paton, Sergio L. Pereira, Jo-Anne Herbrick, Richard F. Wintle, Daniele Merico, Jennifer Howe, Jeffrey R. MacDonald, Chao Lu, Thomas Nalpathamkalam, Wilson W.L. Sung, Zhuozhi Wang, Rohan V. Patel, Giovanna Pellecchia, John Wei, Lisa J. Strug, Sherilyn Bell, Barbara Kellam, Melanie M. Mahtani, Anne S. Bassett, Yvonne Bombard, Rosanna Weksberg, Cheryl Shuman, Ronald D. Cohn, Dimitri J. Stavropoulos, Sarah Bowdin, Matthew R. Hildebrandt, Wei Wei, Asli Romm, Peter Pasceri, James Ellis, Peter Ray, M. Stephen Meyn, Nasim Monfared, S. Mohsen Hosseini, Ann M. Joseph-George, Fred W. Keeley, Ryan A. Cook, Marc Fiume, Hin C. Lee, Christian R. Marshall, Jill Davies, Allison Hazell, Janet A. Buchanan, Michael J. Szego, Stephen W. Scherer

CMAJ. 2018 Feb 5; 190(5): E126–E136. Published online 2018 Feb 3. doi: 10.1503/cmaj.171151